BFRI logo

Biofrontera Inc. Common Stock


BFRI: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.


Show BFRI Financials

Consumer Interest
SEC Filings

Recent trades of BFRI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BFRI's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $5,000 Jul 11, 2019 Issue: Health Issues
  • $5,000 Apr 16, 2019 Issue: Health Issues
  • $5,000 Jan 11, 2019 Issue: Health Issues
  • $5,000 Oct 19, 2018 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard

Number of mentions of BFRI in WallStreetBets Daily Discussion


Recent insights relating to BFRI

CNBC Recommendations

Recent picks made for BFRI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BFRI

Corporate Flights

Flights by private jets registered to BFRI